Latest data from September 24, 2021
Number of Health Center respondents = 20 (74% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 5,101 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 54.05% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 971 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 52.51% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 37.60% | 39.96% |
| White, Hispanic/Latino Patients | 12.15% | 10.81% |
| Black/African American, Non-Hispanic/Latino Patients | 19.21% | 22.76% |
| Black/African American, Hispanic/Latino Patients | 0.90% | 0.00% |
| Asian Patients3 | 3.63% | 1.24% |
| American Indian/Alaska Native Patients3 | 0.24% | 0.10% |
| Native Hawaiian/Other Pacific Islander Patients3 | 2.16% | 1.75% |
| Patients with More than one race3 | 1.96% | 2.99% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 3.98% | 4.53% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 0.80% | 1.44% |
| Unreported/Refused to Report Race and Ethnicity | 17.37% | 14.42% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 1,126 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 68.85% |
| COVID-19 Immunization Series Completed | 1,581 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 67.74% |
| COVID-19 Immunization Series Additional | 207 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 32.54% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 28.69% | 29.10% | 55.07% |
| White, Hispanic/Latino Patients | 21.85% | 25.68% | 5.80% |
| Black/African American, Non-Hispanic/Latino Patients | 22.65% | 15.24% | 16.43% |
| Black/African American, Hispanic/Latino Patients | 0.80% | 0.57% | 0.48% |
| Asian Patients3 | 0.44% | 0.95% | 0.97% |
| American Indian/Alaska Native Patients3 | 0.09% | 0.32% | 0.97% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.62% | 0.76% | 0.00% |
| Patients with More than one race3 | 2.58% | 2.40% | 0.97% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 14.39% | 15.18% | 0.97% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 1.33% | 1.58% | 1.45% |
| Unreported/Refused to Report Race and Ethnicity | 6.57% | 8.22% | 16.91% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 40.00% |
| 1 to 24 Hours | 25.00% |
| More Than 24 Hours | 30.00% |
| N/A | 5.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 10.00% |
| Staffing to administer the vaccine | 20.00% |
| Vaccine confidence | 45.00% |
| Vaccine storage capacity | 5.00% |
| Vaccine supply | 5.00% |
| Other | 0.00% |
| None | 25.00% |
Operations and Staff
| Metrics | Value |
|---|---|
| Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits | 92.50% |
| Average Percent of Health Center Visits Conducted Virtually | 12.00% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 45.00% |
| Number of Mobile Van Sites | 10 |
| Number of Pop-up Clinics | 18 |
| Number of School-Based Vaccination Sites | 3 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 0.00% |
| Refer patients to another organization that provides monoclonal antibody therapies | 50.00% |
| None | 50.00% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 25.00% |
| Patient awareness/education | 10.00% |
| Staffing capacity | 15.00% |
| Therapy administration/onsite logistics | 25.00% |
| Other | 10.00% |
| None | 50.00% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
